DraftKings and FanDuel are reportedly in talks to merge as protracted fights over the legality of the daily fantasy sports games they provide take their toll on both companies’ finances. Some legal experts argue, however, that the odds of antitrust regulators approving such a deal are slim.
Investors in the two companies have been pushing DraftKings, which is based in Boston, and FanDuel, headquartered in New York, to join forces for a while, Bloomberg reported, citing people familiar with the situation. The talks were still at a preliminary stage and could fall apart, the news service said.
FanDuel declined to comment on the Bloomberg story. DraftKings spokesperson Femi Wasserman said, “These rumors have existed for as long as both companies have been in operation. We don’t comment on speculation.”
“There are two glaring problems with even suggesting a merger between FanDuel and DraftKings,” said Marc Edelman, an associate law professor at the Zicklin School of Business, Baruch College, City University of New York. “A merger between the No. 1 and No. 2 companies in any marketplace where those companies have an overwhelming share of the market is going to lead to significant antitrust scrutiny from the regulators whether it be the FTC or the DOJ.”.
Not only was it “incredibly unlikely” that such a merger would survive antitrust scrutiny, but going through the process would open up DraftKings and FanDuel to additional scrutiny of their business practices and would subject their senior officers to “investigational hearings,” he said.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas